Evidence map›Paper›PMID 42236968›Full record

ArticleLeukemia2026

Inotuzumab ozogamicin in individuals with Down syndrome and acute lymphoblastic leukemia.

Amanda M Li, Catherine Aftandilian, Colleen Annesley, Susan Colace, Kelly E Faulk, Joshua W Goldman, Erin Guest, Ammar Hayani, Richard Ho, Elias Jabbour and 14 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Leukemia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Amanda M LiBC Children's Hospital, University of British Columbia, Vancouver, BC, Canada. ali3@cw.bc.ca.ORCID http://orcid.org/0000-0001-8099-9501
Catherine AftandilianDivision of Pediatric Oncology, Hematology, Stem Cell Transplant and Regenerative Medicine, Stanford University, Palo Alto, CA, USA.
Colleen AnnesleyDepartment of Pediatrics, University of Washington, Seattle Children's Hospital, Seattle, WA, USA.
Susan ColaceDivision of Pediatric Hematology, Oncology, and Bone Marrow Transplantation, Nationwide Children's Hospital, Columbus, OH, USA.
Kelly E FaulkDepartment of Pediatrics and Children's Hospital Colorado, University of Colorado, Aurora, CO, USA.
Joshua W GoldmanDepartment of Pediatrics, University of Michigan, Ann Arbor, MI, USA.
Erin GuestChildren's Mercy Kansas City, Division of Hematology, Oncology, and Bone Marrow Transplant, Kansas City, MO, USA.ORCID http://orcid.org/0000-0003-2482-5608
Ammar HayaniAnn and Robert H. Lurie Children's Hospital of Chicago, Department of Pediatric Hematology-Oncology, Chicago, IL, USA.
Richard HoPediatric Hematology, Oncology and Bone Marrow Transplant, Vanderbilt University Medical Center, Nashville, TN, USA.
Elias JabbourThe University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, TX, USA.ORCID http://orcid.org/0000-0003-4465-6119
Anjali Khanna-FarberChildren's Healthcare of Atlanta, Emory University, Atlanta, GA, USA.
Wade KyonoDepartment of Pediatrics, University of Hawaii John A. Burns School of Medicine and Kapiolani Medical Center for Women and Children, Honolulu, HI, USA.
Kasey LegerDepartment of Pediatrics, University of Washington, Seattle Children's Hospital, Seattle, WA, USA.
Kelly MaloneyDepartment of Pediatrics and Children's Hospital Colorado, University of Colorado, Aurora, CO, USA.
David McCallThe University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, TX, USA.ORCID http://orcid.org/0000-0003-2297-9670
Tamara MillerChildren's Healthcare of Atlanta, Emory University, Atlanta, GA, USA.
Holly L PacentaDivision of Hematology and Oncology, Cook Children's Medical Center, Fort Worth, TX, USA.
Troy C QuiggDivision of Pediatric Bone Marrow Transplantation and Cellular Therapy, Corewell Health Helen DeVos Children's Hospital and Michigan State University College of Human Medicine, Grand Rapids, MI, USA.
Jeremy D RubinsteinDepartment of Pediatrics, University of Cincinnati College of Medicine and Division of Oncology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Eric SchaferTexas Children's Cancer and Hematology Center, Baylor College of Medicine, Houston, TX, USA.
Susan R RheingoldDivision of Oncology and Cellular Therapy, Children's Hospital of Philadelphia, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0001-8025-6767
Deepa BhojwaniDivision of Hematology-Oncology, Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0002-7559-7927
Maureen M O'BrienDepartment of Pediatrics and Children's Hospital Colorado, University of Colorado, Aurora, CO, USA.
Karen R RabinDivision of Pediatric Oncology, University of California San Francisco, San Francisco, CA, USA. karen.rabin@ucsf.edu.ORCID http://orcid.org/0000-0002-4081-8195

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42236968

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.